12:00 AM
Sep 24, 2012
 |  BC Week In Review  |  Company News  |  Deals

Astellas, KEK deal

Astellas partnered with High Energy Accelerator Research Organization (KEK) to use synchrotron x-ray crystallography to discover drugs for neglected tropical diseases. The partners will design pharmaceuticals based on the 3-D structure of proteins...

Read the full 145 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >